{
    "_id": {
        "$oid": "6682e8eec4e5dba5ffba280e"
    },
    "CID": {
        "$numberInt": "11016"
    },
    "Name": "TEPA",
    "IUPACName": "1-[bis(aziridin-1-yl)phosphoryl]aziridine",
    "CanonicalSMILES": "C1CN1P(=O)(N2CC2)N3CC3",
    "Synonyms": [
        "Triethylenephosphoramide",
        "TEPA",
        "545-55-1",
        "Aphoxide",
        "Tris(1-aziridinyl)phosphine oxide",
        "TAPO",
        "Imperon fixer T",
        "Triaziridinophosphine oxide",
        "Triethylenephosphorotriamide",
        "Triaziridinylphosphine oxide",
        "Triethylene phophoramide",
        "Triethylene phosphoramide",
        "\"Aziridine",
        "1,1,1-phosphinylidynetris-\"",
        "Phosphoric acid triethylene imide",
        "Tris(1-aziridine)phosphine oxide"
    ],
    "IsomericSMILES": "C1CN1P(=O)(N2CC2)N3CC3",
    "INCHI": "InChI=1S/C6H12N3OP/c10-11(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2",
    "INCHIKEY": "FYAMXEPQQLNQDM-UHFFFAOYSA-N",
    "Formula": "C6H12N3OP",
    "MolecularWeight": {
        "$numberDouble": "173.15"
    },
    "Description": "Tris(1-aziridinyl)phosphine oxide is a phosphoramide.",
    "XlogP": {
        "$numberDouble": "-0.6"
    },
    "Complexity": {
        "$numberInt": "194"
    },
    "Charge": {
        "$numberInt": "0"
    },
    "mechanism_of_action": [
        {
            "References": "Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1260",
            "Value": "THE MOST IMPORTANT PHARMACOLOGICAL ACTIONS OF THE ALKYLATING AGENTS ARE THOSE THAT DISTURB THE FUNDAMENTAL MECHANISMS CONCERNED WITH CELL GROWTH, MITOTIC ACTIVITY, DIFFERENTIATION, & FUNCTION. THE CAPACITY OF THESE DRUGS TO INTERFERE WITH NORMAL MITOSIS & CELL DIVISION IN ALL RAPIDLY PROLIFERATING TISSUES PROVIDES THE BASIS FOR THEIR THERAPEUTIC APPLICATIONS & FOR MANY OF THEIR TOXIC PROPERTIES. /ALKYLATING AGENTS/"
        }
    ],
    "non_human_toxicity_excerpts": [
        {
            "References": "IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V9 80",
            "Value": "SHERMAN RATS WERE TREATED IP WITH 5-10 MG/KG BODY WT ON 11TH DAY OF PREGNANCY: HIGHER DOSES...TOXIC TO MOTHERS & CAUSED SOME FETAL RESORPTIONS & DECR FETAL & PLACENTAL WT. AT DOSES TOLERATED BY MOTHERS MANY RESORPTIONS...OBSERVED; BUT...NO MALFORMATIONS WERE SEEN. FRESHLY-PREPARED SUSPENSIONS OF 5 MG/KG TEPA IN SESAME OIL GIVEN IM TO WISTAR RATS ON THE 4TH & 5TH, 7TH & 8TH OR 11TH & 12TH DAY OF GESTATION CAUSED RESORPTION OF ALMOST ALL FETUSES."
        },
        {
            "References": "IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V9 80",
            "Value": "TEPA INDUCES BACK-MUTATIONS OF AUXOTROPHIC STRAIN OF SCHIZOSACCHAROMYCES POMBE, DOMINANT LETHALS IN MUSCA DOMESTICA & DOMINANT LETHALS, SEX-LINKED RECESSIVE LETHALS & Y-II-III CHROMOSOME TRANSLOCATIONS IN DROSOPHILA MELANOGASTER."
        },
        {
            "References": "IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V9 80",
            "Value": "FREQUENCIES OF DOMINANT LETHALS WERE SIGNIFICANTLY INCR IN PROGENY OF MALE SWISS MICE GIVEN IP INJECTIONS OF TEPA @ DOSES RANGING FROM 0.156-20 MG/KG BODY WT. ...SIMILAR RESULTS IN A/L & C57BL/6J MICE /HAVE BEEN OBTAINED/. CD RATS GIVEN IP INJECTION OF 10 MG/KG BODY WT TEPA HAD CHROMATID ABERRATIONS IN 87.5% OF BONE-MARROW CELLS. INDUCTION OF TRANSMISSIBLE TRANSLOCATIONS HAS BEEN FOUND AFTER SINGLE IP INJECTIONS OF TEPA IN MALE SWISS ALBINO & A/L MICE."
        },
        {
            "References": "U. S. Department of the Interior, Fish & Wildlife Service, Bureau of Sport Fisheries & Wildlife. Handbook of Toxicity of Pesticides to Wildlife. Washington, D. C.: U. S. Government Printing Office, 1970., p. 111",
            "Value": "ACUTE /ORAL/ SYMPTOMS /IN WILD BIRD SPECIES/: ATAXIA, WING DROP, TACHYPNEA, DYSPNEA, NUTATIONS, TREMORS...PROSTRATION, REPEATED WING-BEAT CONVULSIONS. MORTALITIES OCCURRED 4 HR TO 10 DAYS AFTER TREATMENT."
        },
        {
            "References": "U. S. Department of the Interior, Fish & Wildlife Service, Bureau of Sport Fisheries & Wildlife. Handbook of Toxicity of Pesticides to Wildlife. Washington, D. C.: U. S. Government Printing Office, 1970., p. 111",
            "Value": "THE 30-DAY EMLD /EMPIRICAL MINIMUM LETHAL DOSAGE: LOWEST DAILY ORAL DOSAGE THAT PRODUCED 1 OR 2 DEATHS BY END OF THE 30-DAY PERIOD/ FOR CHUKARS IS MORE THAN 1.0 MG/KG/DAY, BUT SURVIVORS OF THIS LEVEL LATER PRODUCED MARKEDLY LESS FERTILE EGGS THAN A CONTROL GROUP RECEIVING EMPTY GELATIN CAPSULES FOR 30-DAY DOSAGE PERIOD."
        },
        {
            "References": "IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V9 78",
            "Value": "6 GROUPS OF WEANLING MALE & FEMALE FISCHER RATS...GIVEN DAILY DOSES OF 0.001-0.3 MG TEPA IN STEROID SUSPENDING VEHICLE...BY GAVAGE ON 5 DAYS/WK FOR 1 YR. AVG SURVIVAL TIMES WERE 240 & 500 DAYS FOR 2 HIGHEST DOSE GROUPS & 560 DAYS FOR OTHER TREATED GROUPS. OF 58 TREATED ANIMALS, 34 DEVELOPED TUMORS: 1 ADENOCARCINOMA, 1 FIBROSARCOMA & 6 FIBROADENOMAS OF MAMMARY GLAND, 10 INTERSTITIAL CELL TUMORS & 1 MESOTHELIOMA OF TESTIS, 1 FIBROMA & 1 FIBROSARCOMA, 1 LUNG ADENOMA, 1 HEPATOMA, 2 BRONCHIAL ADENOMAS, 2 SQUAMOUS-CELL CARCINOMAS OF EAR, 1 SKIN PAPILLOMA, 3 LYMPHOMAS, 2 OTHERS & 1 BASAL-CELL CARCINOMA OF LIP, WHICH WAS ONLY TUMOR OBSERVED @ AREA OF APPLICATION. IN 653 CONTROLS, ONLY 56 TUMORS...OBSERVED @ SITES OTHER THAN THE TESTIS; INCIDENCE OF INTERSTITIAL-CELL TUMORS OF TESTIS WAS 25/26 IN MALES EXAM @ 600 DAYS; MAMMARY FIBROADENOMAS WERE INFREQUENT, BEING FOUND MOSTLY IN OLD FEMALES..."
        },
        {
            "References": "HARTLEY-ASP B; COMPARATIVE CLASTOGENICITY OF ANALOGUES OF THE INSECTICIDE TEPA IN VICIA FABA ROOT-TIP CELLS; MUTAT RES 85 (4): 300 (1981)",
            "Value": "A NUMBER OF TEPA ANALOGUES OF ESTABLISHED CHEMOSTERILITY CONTAINING DIFFERENT NUMBERS OF AZIRIDINE RINGS & WITH SIDE CHAINS OF VARIOUS LENGTHS ARE AVAILABLE. EIGHT ANALOGUES, INCLUDING TEPA & HEMPA, WERE TESTED FOR THEIR ABILITY TO PRODUCE CHROMOSOMAL ABERRATIONS IN VICIA FABA ROOT-TIP CELLS. TEPA & 6 ANALOGUES AT 7.5X10-4 & 10-3 MOLES PRODUCED A SIGNIFICANT INCREASE IN THE CHROMOSOMAL ABERRATION YIELD."
        }
    ]
}